Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis

Details for Australian Patent Application No. 2007328008 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Scott, William; Michels, Martin; Bullion, Ann-Marie; Hentemann, Martin; Redman, Aniko; Rowley, R. Bruce; Wood, Jill; Campbell, Ann-Marie

Agent Davies Collison Cave

Pub. Number AU-A-2007328008

PCT Pub. Number WO2008/070150

Priority 60/873,090 05.12.06 US

Filing date 5 December 2007

Wipo publication date 12 June 2008

International Classifications

A01N 43/54 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/070150 Priority application(s): WO2008/070150

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007328014-Reduction or prevention of dye bleeding

2007328007-Prodrugs and methods of making and using the same